Emerging and Male Contraceptive Methods
On this page
Direct answer
Emerging male contraceptive methods aim to suppress sperm production or block sperm transport, offering options beyond condoms and the permanence of vasectomy. The main candidates are hormonal combinations of testosterone with a progestin, which suppress gonadotropins, and non-hormonal intravas polymers such as RISUG. None is yet in routine use, and a large hormonal trial was stopped early because of side effects.
What you must remember
- Hormonal suppression: testosterone combined with a progestin reduces gonadotropins and sperm output, and effective methods aim for a near-absence of sperm in the ejaculate.
- Side effects: acne, mood change, libido change and weight gain were the main complaints in hormonal trials.
- Gossypol: a cotton-seed derivative that suppressed sperm but caused hypokalaemia and, in some men, irreversible infertility, so it was abandoned.
- RISUG: a polymer injected into the vas deferens forms a barrier to sperm passage and can be reversed by a chemical flush; it remains investigational.
- Vasalgel: a similar polymer under development outside India, with an analogous reversible mechanism.
- Vasectomy confirmation: success is confirmed by semen analysis after clearance, usually at about three months or after around 20 ejaculations.
- Male sterilisation in India: no-scalpel vasectomy is quick and safe, yet male sterilisation remains far less common than female sterilisation.
A development pathway for a new male method
A new male contraceptive must show that it suppresses sperm reliably, is reversible and causes few side effects before it can reach the market. The steps below describe how a candidate moves through the process.
- Establish mechanism: show how the agent blocks sperm production or transport in laboratory and animal studies before any human use.
- Test suppression: measure sperm counts in men to reach azoospermia or a very low threshold, the endpoint that defines effective suppression.
- Measure safety: monitor mood, libido, lipids, blood counts, prostate markers and bone health over long periods.
- Confirm efficacy in couples: follow couples for unintended pregnancy over a defined period, as in female contraceptive trials.
- Test reversibility: show that sperm counts recover after stopping the agent, measured over several months.
- Seek licensing: submit data to regulators, with a plan for affordability and access in public programmes.
Each stage can end a candidate, as hormonal trials showed when side effects outweighed the benefit. Demonstrating reversibility is often the hardest step for implanted agents.
Where the exam tries to catch you
Questions here test whether the student knows what is established and what is still under study.
- Trap: Claiming a male hormonal method is already in routine use. Correct: Male hormonal contraception remains investigational, while condoms and vasectomy are the established male methods.
- Trap: Treating gossypol as a safe reversible option. Correct: Gossypol caused hypokalaemia and irreversible infertility in some men, so it was abandoned.
- Trap: Calling vasectomy effective on the day of surgery. Correct: Protection is confirmed only by a semen analysis after clearance, so another method is needed until then.
- Trap: Confusing RISUG with a hormonal injection. Correct: RISUG is a non-hormonal polymer placed in the vas deferens, which blocks sperm passage.
Frequently asked questions
Which male hormonal contraceptive methods are being studied?
The main candidates combine testosterone with a progestin, given as injections or gels, to suppress gonadotropins and sperm production. Newer oral agents are also under study. None is yet licensed for routine use, so efficacy and side effects remain under evaluation.
What is RISUG and how does it work?
RISUG, which stands for reversible inhibition of sperm under guidance, involves injecting a polymer into the vas deferens so that it blocks sperm passage. The polymer can be dissolved by a chemical flush to restore fertility. It remains investigational and is not yet widely available.
Why was gossypol abandoned as a male contraceptive?
Gossypol, a cotton-seed derivative, suppressed sperm production but caused hypokalaemia and, in some men, irreversible infertility. Those toxic effects made it unacceptable for routine contraception. It therefore never reached general use.
How is success of a vasectomy confirmed?
Success is confirmed by semen analysis after clearance, usually at about three months or after around 20 ejaculations. Until a sperm-free sample is confirmed, the couple should use another contraceptive method. The no-scalpel technique is quick and well tolerated.